Healthcare -
Biotechnology - NASDAQ - US
$ 4.24
-0.703 %
$ 6.54 M
Market Cap
-1.59
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
56.31%
EBIT
Estimate
--29.03%
Net Income
Estimate
34.80%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Xenetic Biosciences, Inc.
XBIO has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart XBIO
EBIT FORECAST
EBIT Forecast Chart XBIO
NET INCOME FORECAST
Net Income Chart XBIO